These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 11520324

  • 1. Tiagabine (gabitril) experience in children.
    Pellock JM.
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC.
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [Abstract] [Full Text] [Related]

  • 5. Tiagabine.
    Schachter SC.
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K.
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [Abstract] [Full Text] [Related]

  • 8. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B, Stelmasiak Z.
    Neurol Neurochir Pol; 2008 Mar; 42(4):303-11. PubMed ID: 18975234
    [Abstract] [Full Text] [Related]

  • 9. International experience with tiagabine add-on therapy.
    Ben-Menachem E.
    Epilepsia; 1995 Mar; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tiagabine: the safety landscape.
    Leppik IE.
    Epilepsia; 1995 Mar; 36 Suppl 6():S10-S13. PubMed ID: 8595787
    [Abstract] [Full Text] [Related]

  • 12. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study.
    Uldall P, Bulteau C, Pedersen SA, Dulac O, Lyby K.
    Epilepsy Res; 2000 Dec; 42(2-3):159-68. PubMed ID: 11074188
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R.
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.
    Sackellares JC, Krauss G, Sommerville KW, Deaton R.
    Epilepsia; 2002 Apr; 43(4):394-8. PubMed ID: 11952769
    [Abstract] [Full Text] [Related]

  • 18. Tiagabine in clinical practice.
    Genton P, Guerrini R, Perucca E.
    Epilepsia; 2001 Apr; 42 Suppl 3():42-5. PubMed ID: 11520322
    [Abstract] [Full Text] [Related]

  • 19. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC, Noble S.
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.